ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Reservations Now Open: Psychedelic Science Newsroom for Official Announcements and Media Events at PS2025

  • Businesses, institutions, and movement leaders are invited to share announcements at the world's largest psychedelic conference
  • Reserve a fully-supported press space with promotion in PS2025 materials
  • Shape the public narrative by engaging trusted media outlets covering the future of psychedelic research, policy, and culture

DENVER, April 24, 2025 (GLOBE NEWSWIRE) -- Psychedelic Science 2025 (PS2025)—the premier global gathering for psychedelic research, medicine, policy, and culture hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS)—announces the Psychedelic Science Newsroom, a dedicated hub for official announcements and direct engagement with global media. Businesses, institutions, and movement leaders are now invited to share meaningful updates by submitting a reservation request via this reservation form.

With hundreds of speakers, thousands of attendees, and attendance from media outlets such as 60 Minutes, Al Jazeera, The Atlantic, CNN, Forbes, The Independent, and WIRED, PS2025 presents a rare opportunity for leaders to share significant developments with the most engaged psychedelic audience in the world.

The stories we share through trusted media don’t just inform—they influence. Thoughtful engagement with the press has the power to build public understanding, reduce stigma, drive investment, and shift the cultural and political landscapes. The Psychedelic Science Newsroom provides leaders a platform to help drive awareness and guide how psychedelics are integrated into our society.
Zane Bader, Communications Manager, MAPS

As public interest in psychedelics accelerates and policies evolve, those leading innovation have a unique opportunity—and responsibility—to shape the public narrative. Whether announcing a major partnership, launching a clinical trial, debuting new research, or introducing a new product, the Psychedelic Science Newsroom offers a highly visible and credible platform to demonstrate leadership, build credibility, and influence how the future of this field is perceived.

Reservation slots are limited and will be granted on a first-come, first-served basis. A nominal reservation fee supports on-site production and staffing.

Each confirmed presenter will receive:

  • Access to a fully equipped press room inside the Colorado Convention Center
  • A/V support for multimedia presentations
  • Promotion of your press event in official PS2025 materials
  • On-site coordination and media support from the PS2025 press team

In keeping with the conference theme—The Integration—the Psychedelic Science Newsroom encourages announcements that reflect:

  • Integration of science and policy
  • Expansion of community-based healing models
  • Ethical business innovation in psychedelics
  • Advances in clinical trials or therapeutic protocols
  • Cross-sector and cross-cultural collaborations

Psychedelic Science 2025 is not only where research, therapy, and culture converge—it's where the future of this movement is being written, debated, and shared with the world. With international media attendance and press outlets covering the future of psychedelic medicine, policy reform, investment, and public health, this is your chance to amplify your work in front of the world's most informed and invested audience.

Request your press slot now with this form, and contact media@psychedelicscience.org for questions about the Psychedelic Science Newsroom.

This announcement follows PS2025's expansion of its lineup of expert speakers, with hundreds more to be announced in the coming weeks—along with additional workshops, sessions, and programming. Find more information about PS2025 registration, hotel bookings, sponsorship, or exhibitor opportunities, and speakers at psychedelicscience.org.

About Psychedelic Science
Psychedelic Science 2025 (PS2025), hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS), is the world’s leading psychedelic conference. Returning to the Colorado Convention Center in Denver from June 16-20, 2025, this five-day event brings together a global community of scientists, therapists, policymakers, cultural leaders, and advocates to explore the forefront of psychedelic research, therapy, and culture. Facilitated by Superfly, known for producing iconic events such as Bonnaroo and Outside Lands, PS2025 will feature expert speakers; hands-on workshops; community events with art, music, and mindfulness activities; and scholarship opportunities to support broad participation.

Since its inception in 2010, the Psychedelic Science conference series has fostered knowledge-sharing, collaboration, and community-building within the psychedelic ecosystem. Join thousands of attendees as we explore the transformative potential of psychedelics and shape the future of mental health, policy, and cultural understanding. For more information and registration details, visit psychedelicscience.org, and follow us on X, Instagram, LinkedIn, and Facebook.

ABOUT MAPS
Founded in 1986, MAPS is a 501(c)(3) nonprofit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS' conference flagship, Psychedelic Science, has been the leading convening of the psychedelic community since 2010. MAPS incubated Lykos Therapeutics, a drug-development public benefit company, and the Zendo Project, a leader in psychedelic harm reduction. Since MAPS was founded, philanthropic donors and grantors have given more than $150 million to advance research, change drug policy, and evolve education in the field of psychedelics.

CONTACT
media@psychedelicscience.org


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.